EUVIMEDEUVIMED entdecken
Fallbericht

Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report

Eva-Maria Pichler iD, Wolfram Kawohl, Erich Seifritz, Patrik Roser

The International Journal of Psychiatry in Medicine · 2019-03 · 54 (2) · 150-156

DOI: 10.1177/0091217418791455 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The International Journal of Psychiatry in Medicine, online erschienen am 30.07.2018. Verfasst von Eva-Maria Pichler und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Psychiatry and Psychotherapy, Psychiatric Services Aargau AG, Brugg, Switzerland. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Anecdotal reports and preliminary studies suggest a therapeutic potential of cannabis in Tourette syndrome. We report the case of a female patient suffering from treatment-resistant Tourette syndrome.

Methods

Guideline-directed antipsychotic treatment with risperidone and aripiprazole as well as pure delta-9-tetrahydrocannabinol had no significant effect on Tourette syndrome symptomatology.

Results

Following administration of a daily dosage of 10 mg delta-9-tetrahydrocannabinol combined with 20 mg cannabidiol (CBD), the patient showed a rapid and highly significant improvement in the Yale Global Tic Severity Scale.

Conclusions

It can be speculated whether the beneficial effects may rely on the pharmacological properties of cannabidiol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdolescentCannabidiolCannabinoid Receptor ModulatorsDronabinolDrug Therapy, CombinationFemaleHumansTourette Syndrome

Stichwörter der Autor:innen

Tourette syndromecannabidiolcannabisdelta-9-tetrahydrocannabinoltic disorders

Substanzen

Cannabinoid Receptor ModulatorsCannabidiolDronabinol

Autor:innen und Institutionen

  • 1 Department of Psychiatry and Psychotherapy, Psychiatric Services Aargau AG, Brugg, Switzerland.
  • 2 Department for Psychiatry, Psychotherapy and Psychosomatics, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Eva-Maria Pichler

Zitieren

APA

Pichler, E. M., Kawohl, W., Seifritz, E., & Roser, P. (2019). Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report. The International Journal of Psychiatry in Medicine, 54(2), 150-156. https://doi.org/10.1177/0091217418791455

Vancouver

Pichler EM, Kawohl W, Seifritz E, Roser P. Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report. The International Journal of Psychiatry in Medicine. 2019;54(2):150-156. doi:10.1177/0091217418791455

BibTeX
@article{Pichler2019,
  author = {Pichler, Eva-Maria and Kawohl, Wolfram and Seifritz, Erich and Roser, Patrik},
  title = {Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report},
  journal = {The International Journal of Psychiatry in Medicine},
  year = {2019},
  volume = {54},
  number = {2},
  pages = {150--156},
  doi = {10.1177/0091217418791455}
}
Kostenlos starten →